INS and type 2 diabetes mellitus: Glucose transporter 4 (GLUT4) is one of the most appealing targets for treating T2DM, and the translocation of GLUT4 and the expression levels of GLUT4 are related to systemic insulin-mediated glucose homeostasis (16).